Meloxicam Eg

Meloxicam, the active ingredient in Meloxicam Eg, is a Nonsteroidal anti-inflammatory drug (NSAID) presented as an oral dosage form for oral use. It reduces inflammation and pain in conditions such as osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and acute musculoskeletal pain, and is prescribed for adult patients requiring anti‑inflammatory therapy and is commonly used in chronic inflammatory disorders.

GNH USA supplies Meloxicam Eg as a licensed, GDP‑compliant international pharmaceutical product serving hospitals, pharmacies, clinics and procurement teams worldwide, adhering to EU quality standards and regulatory requirements.

Meloxicam is an NSAID that reduces inflammation by inhibiting COX‑2, and it is indicated for several musculoskeletal and inflammatory conditions.

- Osteoarthritis: reduces joint pain and improves mobility. - Rheumatoid arthritis: alleviates synovial inflammation and joint swelling. - Ankylosing spondylitis: diminishes spinal pain and stiffness. - Acute musculoskeletal pain: provides rapid relief of pain and inflammation.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia, or abdominal pain. - Headache or dizziness. - Mild skin rash or pruritus.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding. - Cardiovascular events such as myocardial infarction or stroke. - Severe hepatic or renal impairment. - Anaphylactic or severe hypersensitivity reactions. - Stevens‑Johnson syndrome or toxic epidermal necrolysis.

Before initiating therapy, consider the following precautions: - Assess renal function: monitor serum creatinine and eGFR. - Evaluate hepatic status: avoid use in severe liver disease. - Review cardiovascular risk: use cautiously in patients with a history of heart disease. - Avoid in patients with known hypersensitivity to NSAIDs. - Use the lowest effective dose for the shortest duration needed. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Meloxicam may interact with several drug classes.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of bleeding. - Other NSAIDs or aspirin: heightened gastrointestinal toxicity. - Lithium: elevated lithium serum levels. - Methotrexate: reduced renal clearance and increased toxicity. - ACE inhibitors or ARBs: potential for reduced renal function.

Moderate Interactions (Monitor Closely): - Diuretics: possible reduction in antihypertensive effect. - SSRIs or SNRIs: additive bleeding risk. - Corticosteroids: increased risk of gastrointestinal ulceration. - Cyclosporine: enhanced nephrotoxicity. - Beta‑blockers: may mask tachycardia from fluid loss.